We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
No comments yet, be the first to start the discussion!
Chemotherapy due to high Ki67
Bogdan Cristian Dinu
Chemo based by PgR level , LVI and Ki67
Chemotherapy should be recommended. The benefit and potential hazard should be fully discussed with the patient, based on her high Ki67, LVI, relatively young age. Besides, information related to tumor grade and menopausal status should be provided for detailed discussion.
chemioterapia seguita da ormonoterapia (Google translate: chemotherapy followed by hormonal therapy)
Chemo due to age, male and Ki67
QT + HT
Why performing Oncotype, if you don't follow its recommendation.
Ki67 of final path report should be considered. Oncotype score could also be reliable in males. However I think the most necessary issue should be to check BRCA and other germline mutations in this guy. Eventually I want to start him tamoxifen for 5 years with close follow-up
JULIO CESAR VELASCO RODRIGUEZ
oncotype in male breast cancer is rarely used, but it serves to avoid over-treating patients, experience is limited, but would only indicate hormonal therapy based on the oncotype score
Male Breast Cancer is highly sensitive to Hormonal therapy. So it is generally the preferred first option of treatment.
In addition to endocrine therapy, a case can be made to adding chemotherapy to high risk patients(such as those with Lymph node metastases.
Since this patient has node negative disease, I would not recommend any chemotherapy. Instead use endocrine therapy such as Tamoxifen for a duration of 5 years.
Sewa S. Legha, MD
Del Barco Sonia
First, if you do oncotype .. you follow it or not?
Second, in case of woman i choose chemo because age and therefore in this case, the same
Ludwing Bacon Fonseca
If I send a Genomic profile.... I should follow the recommendation.... so my personal opinion with all information is : Tamoxifen x 5a
Pending Moderator approval.
Are you sure you want to delete this comment? This can't be undone.